Simeon I. Taylor
Affiliations: | The George Washington University, Washington, DC, United States | ||
| 2013- | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Molecular Biology, Genetics, Entomology BiologyWebsite:
http://www.medschool.umaryland.edu/profiles/Taylor-Simeon/Google:
"Simeon Taylor"Parents
Sign in to add mentor| Robert L. Jungas | grad student | 1974 | Harvard Medical School | |
| (Studies on the regulation of pyruvate oxidation in adipose tissue and liver.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Beitelshees AL, Streeten EA, Shahidzadeh Yazdi Z, et al. (2024) Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test. Clinical and Translational Science. 17: e13809 |
| Taylor SI, Shahidzadeh Yazdi Z, Oral EA. (2024) Letter to the Editor From Taylor et al "Type B Insulin Resistance Syndrome: A Rare Cause of Hypoglycemia". Jcem Case Reports. 2: luae001 |
| Galderisi A, Tamborlane W, Taylor SI, et al. (2022) SGLT2i Improves Glycemic Control in Patients With Congenital Severe Insulin Resistance. Pediatrics |
| Taylor SI, DiMarchi RD. (2020) Smarter Modeling to Enable a Smarter Insulin. Diabetes. 69: 1608-1610 |
| Barbetti F, Taylor SI. (2019) Insulin: still a miracle after all these years. The Journal of Clinical Investigation. 130 |
| Cefalu WT, Dawes DE, Gavlak G, et al. (2018) Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311. Diabetes Care |
| Cefalu WT, Dawes DE, Gavlak G, et al. (2018) Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care |
| Blau JE, Tella SH, Taylor SI, et al. (2017) Ketoacidosis and SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes/Metabolism Research and Reviews |
| Sun XJ, Kim SP, Zhang D, et al. (2017) Deletion of interleukin 1 receptor associated kinase 1 (IRAK1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle. The Journal of Biological Chemistry |
| Taylor SI, Blau JE, Rother KI. (2015) Perspective: SGLT2 inhibitors may predispose to ketoacidosis. The Journal of Clinical Endocrinology and Metabolism. jc20151884 |